...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: New SEDAR page
4
Aug 02, 2023 02:29PM

Aug 03, 2023 11:06AM
3
Aug 03, 2023 11:47AM
1
Aug 06, 2023 07:54AM

"Distributions as reported in these past months to get it done on time if that is the main reason"

Well no response from IR yet. Probably putting together their creative juices looking for a response.

1
Aug 08, 2023 04:16PM

Aug 10, 2023 08:15AM

Aug 10, 2023 12:55PM
Share
New Message
Please login to post a reply